Development of gene targeting in C. elegans and D. rerio using zinc finger
使用锌指开发秀丽隐杆线虫和斑马鱼基因打靶
基本信息
- 批准号:7085142
- 负责人:
- 金额:$ 17.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-06-01 至 2008-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): The goal of this research is to develop methods for the precise modification of specific target genes in two important genetic model organisms, the nematode Caenorhabditis elegans and the zebrafish Danio rerio. Both nematodes and fish are powerful experimental systems that combine elegant developmental biology with large scale genetics. Both systems have contributed to our understanding of fundamental problems in cancer biology, including programmed cell death, the control of organogenesis, the interaction of cancer susceptibility genes with the environment, and the genetics of melanoma. An important limitation of these model systems is that techniques for site-specific manipulation of the genome are not currently available in either nematodes or fish. Thus, in contrast to murine embryonic stem cells and the yeast S. cerevisiae, it is not possible to knock out specific genes or to precisely control the time and place of gene expression. In the last two years, a powerful new approach to gene-targeting has been developed and successfully used in flies and in mammalian somatic cells. This technique uses chimeric zinc finger nucleases to stimulate precise targeting of specific genes in their native genomic context. The aim of this proposal is to induce targeted, heritable genetic changes via zinc finger nuclease-mediated homologous recombination in C. elegans and D. rerio. Initially we will employ a well-characterized zinc finger nuclease that recognizes the green fluorescent protein (GFP) gene. We will introduce the nuclease into transgenic nematodes and zebrafish that express GFP. We expect the resulting double-strand DNA breaks to stimulate mutagenic non-homologous end joining (NHEJ), leading to the loss of GFP signal. In the second phase, we will simultaneously introduce the nuclease and a repair template that will allow us to create precise mutations in the target locus by homologous recombination. Based on the success of this work we will then target native genes in the worm and the fish by designing novel nucleases and testing them in vitro and in vivo for activity against the targeted gene. We expect that, if successful, this novel approach would be a practical, flexible, and powerful technique that would find wide application, significantly increasing the power of these systems to illuminate human cancer biology.
描述(由申请人提供):本研究的目的是开发用于精确修饰两种重要遗传模式生物(线虫秀丽隐杆线虫和斑马鱼)中特定靶基因的方法。线虫和鱼类都是强大的实验系统,它们将联合收割机优雅的发育生物学与大规模遗传学相结合。这两个系统都有助于我们理解癌症生物学中的基本问题,包括程序性细胞死亡,器官发生的控制,癌症易感基因与环境的相互作用,以及黑色素瘤的遗传学。这些模型系统的一个重要限制是,基因组的位点特异性操作技术目前在线虫或鱼类中不可用。因此,与小鼠胚胎干细胞和酵母S.在酿酒酵母中,不可能敲除特定基因或精确控制基因表达的时间和地点。在过去的两年中,一种强大的新的基因靶向方法已经开发出来,并成功地用于苍蝇和哺乳动物体细胞。该技术使用嵌合锌指核酸酶来刺激特异性基因在其天然基因组环境中的精确靶向。本研究的目的是通过锌指核酸酶介导的同源重组在C. elegans和D.雷里奥。最初,我们将采用一个良好的特点,锌指核酸酶,识别的绿色荧光蛋白(GFP)基因。我们将把核酸酶引入表达GFP的转基因线虫和斑马鱼中。我们预期所产生的双链DNA断裂会刺激致突变的非同源末端连接(NHEJ),导致GFP信号的丢失。在第二阶段,我们将同时引入核酸酶和修复模板,这将使我们能够通过同源重组在靶基因座中产生精确的突变。基于这项工作的成功,我们将通过设计新的核酸酶并在体外和体内测试它们对靶基因的活性来靶向蠕虫和鱼类中的天然基因。我们预计,如果成功,这种新方法将是一种实用,灵活和强大的技术,将得到广泛的应用,显着增加这些系统的能力,以阐明人类癌症生物学。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Matthew H Porteus其他文献
Gene targeting using zinc finger nucleases
利用锌指核酸酶进行基因靶向
- DOI:
10.1038/nbt1125 - 发表时间:
2005-08-08 - 期刊:
- 影响因子:41.700
- 作者:
Matthew H Porteus;Dana Carroll - 通讯作者:
Dana Carroll
Matthew H Porteus的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Matthew H Porteus', 18)}}的其他基金
Homologous Recombination Mediated Gene Correction for the Hemoglobinopathies
同源重组介导的血红蛋白病基因校正
- 批准号:
9982120 - 财政年份:2018
- 资助金额:
$ 17.55万 - 项目类别:
Homologous Recombination Mediated Gene Correction for the Hemoglobinopathies
同源重组介导的血红蛋白病基因校正
- 批准号:
10213813 - 财政年份:2018
- 资助金额:
$ 17.55万 - 项目类别:
Genome Editing by Homologous Recombination to Create HIV Resistant Immune System
通过同源重组进行基因组编辑以创建抗 HIV 免疫系统
- 批准号:
8993696 - 财政年份:2015
- 资助金额:
$ 17.55万 - 项目类别:
Genome Editing by Homologous Recombination to Create HIV Resistant Immune System
通过同源重组进行基因组编辑以创建抗 HIV 免疫系统
- 批准号:
9904901 - 财政年份:2015
- 资助金额:
$ 17.55万 - 项目类别:
Genome Editing by Homologous Recombination to Create HIV Resistant Immune System
通过同源重组进行基因组编辑以创建抗 HIV 免疫系统
- 批准号:
9130095 - 财政年份:2015
- 资助金额:
$ 17.55万 - 项目类别:
Pre-Clinical Development of Nuclease Mediated Gene Therapy for SCID
SCID 核酸酶介导基因疗法的临床前开发
- 批准号:
8438250 - 财政年份:2012
- 资助金额:
$ 17.55万 - 项目类别:
Pre-Clinical Development of Nuclease Mediated Gene Therapy for SCID
SCID 核酸酶介导基因疗法的临床前开发
- 批准号:
9173450 - 财政年份:2012
- 资助金额:
$ 17.55万 - 项目类别:
Pre-Clinical Development of Nuclease Mediated Gene Therapy for SCID
SCID 核酸酶介导基因疗法的临床前开发
- 批准号:
8581640 - 财政年份:2012
- 资助金额:
$ 17.55万 - 项目类别:
Pre-Clinical Development of Nuclease Mediated Gene Therapy for SCID
SCID 核酸酶介导基因疗法的临床前开发
- 批准号:
8777046 - 财政年份:2012
- 资助金额:
$ 17.55万 - 项目类别:
Using Zinc Finger Nucleases to Stimulate Gene Targeting in HSC
使用锌指核酸酶刺激 HSC 中的基因靶向
- 批准号:
7569407 - 财政年份:2006
- 资助金额:
$ 17.55万 - 项目类别:
相似海外基金
The mechanism of oral carcinogenesis by FAT1 gene mutation
FAT1基因突变导致口腔癌的机制
- 批准号:
23K15977 - 财政年份:2023
- 资助金额:
$ 17.55万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of an efficient method combining quantum chemistry and machine learning to evolve PCR technology and gene mutation analysis
开发一种结合量子化学和机器学习的有效方法来发展 PCR 技术和基因突变分析
- 批准号:
22KJ2450 - 财政年份:2023
- 资助金额:
$ 17.55万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Development of preemptive medicine for asymptomatic MEN1 gene mutation carriers
无症状MEN1基因突变携带者的抢先治疗药物开发
- 批准号:
23H03151 - 财政年份:2023
- 资助金额:
$ 17.55万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Elucidation of molecular mechanisms of occurrence of anaplastic thyroid cancer using gene mutation analysis and comprehensive gene expression analysis
利用基因突变分析和综合基因表达分析阐明甲状腺未分化癌发生的分子机制
- 批准号:
23K08067 - 财政年份:2023
- 资助金额:
$ 17.55万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Elucidation of the molecular mechanism of maxillofacial hypoplasia caused by FAT1 gene mutation
FAT1基因突变引起颌面发育不全的分子机制阐明
- 批准号:
22K19629 - 财政年份:2022
- 资助金额:
$ 17.55万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Association between CD79B gene mutation and prognosis in vitreoretinal lymphoma
CD79B基因突变与玻璃体视网膜淋巴瘤预后的关系
- 批准号:
22K09763 - 财政年份:2022
- 资助金额:
$ 17.55万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Gene mutation/expression prediction from clinical images using artificial intelligence technology in pancreatic cancer
利用人工智能技术从临床图像预测胰腺癌基因突变/表达
- 批准号:
20K17570 - 财政年份:2020
- 资助金额:
$ 17.55万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of colorectal carcinogenesis mediated by PTPRK gene mutation
PTPRK基因突变介导的结直肠癌发生机制的阐明
- 批准号:
20K16311 - 财政年份:2020
- 资助金额:
$ 17.55万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the molecular mechanism of development of anaplastic thyroid cancer using gene mutation analysis and comprehensive gene expression analysis
利用基因突变分析和综合基因表达分析阐明甲状腺未分化癌发生的分子机制
- 批准号:
20K08953 - 财政年份:2020
- 资助金额:
$ 17.55万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of next-generation precision medicine targeting the pathways on which driver gene mutation-positive lung cancer depends
针对驱动基因突变阳性肺癌所依赖的途径开发下一代精准医疗
- 批准号:
20H03771 - 财政年份:2020
- 资助金额:
$ 17.55万 - 项目类别:
Grant-in-Aid for Scientific Research (B)